Skip to main content
. Author manuscript; available in PMC: 2021 May 6.
Published in final edited form as: Oncogene. 2020 Nov 6;40(2):396–407. doi: 10.1038/s41388-020-01536-0

Figure 2. The amount of immune cell infiltration in human SHH-MB samples does not correlate with driver mutation.

Figure 2.

(A–D) Representative immunohistochemical staining of Ki67 (A), CD3 (B), CD68 (C) and CD163 (D) from 20 SHH-MB samples. (E–H) Correlation between the staining of Ki67 (E), CD3 (F), CD68 (G) and CD163 (H) and driver mutation. Quantification was done on the region that had the strongest positive signal and a score was given to each sample based on the expression and distribution of positive cells as indicated in (I–J). Mean ± SD. Significance was determined using one-way ANOVA with Tukey post hoc pairwise comparison.